Showing results (341-350 of 1,648) with videos related to
Sort By:
Pageof 165
Indian Journal of Pharmacology|July 18, 2022
Pro-apoptotic, anti-metastatic, and anti-telomerase activity of Tinospora cordifolia and its active polysaccharide arabinogalactan during Benzo(a)pyrene-induced lung carcinogenesisVandana Mohan, Koul AshwaniIndian Journal of Pharmacology|February 1, 2023
Lasmiditan abortive therapy for episodic migraine in Phase II/III randomized clinical trials: A meta-analysisMarya Ahsan, Ayaz Khurram MallickIndian Journal of Pharmacology|February 1, 2023
Paxlovid: A promising drug for the challenging treatment of SARS-COV-2 in the pandemic eraNiraj Niraj, Sonia Shinde Mahajan, Ajay Prakash, et al.Indian Journal of Pharmacology|February 1, 2023
An idiosyncratic reaction of unilateral common peroneal nerve palsy associated with below desired therapeutic range of tacrolimus level in a patient postheart transplantationAyush Srivastava, P Ansuman Abhisek, Shweta Supriya PradhanIndian Journal of Pharmacology|March 24, 2023
Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled studySuhasini Dehury, Sourya Mohapatra, Haribhakti Seba Das, et al.Indian Journal of Pharmacology|March 24, 2023
Successful management of delayed hyaluronidase hypersensitivity after subtenon's anesthesia during the COVID-19 pandemic: A rare case reportBharat Gurnani, Kirandeep KaurIndian Journal of Pharmacology|August 20, 2021
Current concepts and molecular mechanisms in pharmacogenetics of essential hypertensionFarhana Rahman, Nagasundaram Muthaiah, Govindasamy KumaramanickavelIndian Journal of Pharmacology|August 22, 2025
Pharmacokinetic study of the synthetic cannabinoid, 5F-MDMB-PICA, in male Wistar ratsElkhatim Hassan Abdelgadir, Bashayer Mohammed Alharbi, Noor Hassan Dammas, et al.Indian Journal of Pharmacology|August 22, 2025
Safety assessment of dexmedetomidine: Real-world adverse event analysis from the Food and Drug Administration Adverse Events Reporting System public dashboardYi Yin, Jie Jiang, Youpeng JinIndian Journal of Pharmacology|August 22, 2025
A case series of vildagliptin-associated bullous pemphigoid - Rare side effectMohit Kumar Shahi, J V Ashwin, Astha Singh, et al.Pageof 165